Frontiers in Neuroscience (Oct 2023)

Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis

  • Minggang Fang,
  • Sara K. Deibler,
  • Alissa L. Nana,
  • Sarat C. Vatsavayai,
  • Shahid Banday,
  • You Zhou,
  • You Zhou,
  • Sandra Almeida,
  • Alexandra Weiss,
  • Robert H. Brown,
  • William W. Seeley,
  • Fen-Biao Gao,
  • Fen-Biao Gao,
  • Michael R. Green

DOI
https://doi.org/10.3389/fnins.2023.1251228
Journal volume & issue
Vol. 17

Abstract

Read online

A common pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the cytoplasmic mislocalization and aggregation of the DNA/RNA-binding protein TDP-43, but how loss of nuclear TDP-43 function contributes to ALS and FTD pathogenesis remains largely unknown. Here, using large-scale RNAi screening, we identify TARDBP, which encodes TDP-43, as a gene whose loss-of-function results in elevated DNA mutation rate and genomic instability. Consistent with this finding, we observe increased DNA damage in induced pluripotent stem cells (iPSCs) and iPSC-derived post-mitotic neurons generated from ALS patients harboring TARDBP mutations. We find that the increase in DNA damage in ALS iPSC-derived neurons is due to defects in two major pathways for DNA double-strand break repair: non-homologous end joining and homologous recombination. Cells with defects in DNA repair are sensitive to DNA damaging agents and, accordingly, we find that ALS iPSC-derived neurons show a marked reduction in survival following treatment with a DNA damaging agent. Importantly, we find that increased DNA damage is also observed in neurons with nuclear TDP-43 depletion from ALS/FTD patient brain tissues. Collectively, our results demonstrate that ALS neurons with loss of nuclear TDP-43 function have elevated levels of DNA damage and contribute to the idea that genomic instability is a defining pathological feature of ALS/FTD patients with TDP-43 pathology.

Keywords